glp 1 risk factors Long-term Success of GLP-1s Hinges on More Than Just a Prescription Nutritional Resilience in the Age

Patients switch because of efficacy, tolerability, access, cost, insurance coverage, or newer options becoming available

Learn how these drugs affect sodium, potassium, and magnesium levels, recognize warning signs of imbalance, and find practical strategies to maintain healthy electrolyte levels during treatment.

GLP-1 medications are becoming one of the most important workplace health and benefits topics

Glucagon-like peptide-1 receptor agonists show promise for reducing apnea-hypopnea index and body weight in patients with obstructive sleep apnea, offering new treatment options beyond PAP therapy.

Portion-control options in c-stores appealing to GLP-1 consumer.

Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of30 kg/m2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)